查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1128800

全球微創青光眼手術 (MIGS) 設備市場：到 2029 年的行業趨勢和預測

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market - Industry Trends and Forecast to 2029
出版日期: | 出版商: Data Bridge Market Research | 英文 235 Pages | 商品交期: 請詢問到貨日

價格

在 2022-2029 年的預測期內，全球微創青光眼手術 (MIGS) 設備市場規模預計將實現 33.3% 的可觀複合年增長率。

諸如老年人口增加、全球青光眼發病率增加以及政府努力提高防盲意識等因素正在促進市場的增長。

本報告研究全球微創青光眼手術 (MIGS) 設備市場，提供市場概況、驅動因素和限制因素、機遇和挑戰、按細分市場和地區劃分的市場細分、競爭格局以及主要參與者的概況等。

內容

第一章介紹

第 2 章市場細分

第 3 章執行摘要

第 4 章重要注意事項

  • 國際標準
  • 區域標準
  • 主要輿論領袖的市場觀點
  • 未來市場情景預測
  • 調查結果和區域趨勢
  • 競爭分組

第 5 章按國家劃分的手術數量

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第六章規定

  • 美國
  • 歐洲
  • 中國
  • 澳大利亞

第 7 章市場概述

  • 驅動程序
    • 老年人口增加
    • 全球青光眼發病率上升
    • 政府努力提高防盲意識
    • 微創手術在全球日益普及
  • 限制因素
    • 兌換場景不足
    • 對微創青光眼手術 (MIGS) 設備的嚴格規定
    • 手術費用高
  • 機會
    • 從青光眼藥物快速過渡到微創青光眼手術
    • 引進技術先進的產品
  • 任務
    • 缺乏具備足夠知識的熟練專業人員
    • 與微創青光眼手術 (MIGS) 相關的風險

第 8 章全球微創青光眼手術 (MIGS) 設備市場，按產品分類

  • 概覽
  • MIGS 支架
  • MIGS 分流器
  • 其他

第 9 章全球微創青光眼手術 (MIGS) 設備市場：按目標劃分

  • 概覽
  • 小梁網
  • 脈絡膜上腔
  • 結膜下濾過
  • 房水生成減少

第 10 章按手術類型劃分的全球微創青光眼手術 (MIGS) 設備市場

  • 概覽
  • 與白內障相關的青光眼
  • 孤立性青光眼

第 11 章全球微創青光眼手術 (MIGS) 設備市場，按最終用戶分列

  • 概覽
  • 醫院
  • 眼科診所
  • 門診手術中心 (ASCS)
  • 其他

第 12 章全球微創青光眼手術 (MIGS) 設備市場，按分銷渠道劃分

  • 概覽
  • 直接出價
  • 零售

第 13 章按地區分列的全球微創青光眼手術 (MIGS) 設備市場

  • 概覽
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 瑞士
    • 荷蘭
    • 比利時
    • 俄羅斯
    • 土耳其
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印度尼西亞
    • 菲律賓
    • 其他亞太地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 埃及
    • 其他中東/非洲

第 14 章全球微創青光眼手術 (MIGS) 設備市場：公司概況

  • 公司份額分析：全球
  • 公司份額分析：北美
  • 公司份額分析：歐洲
  • 公司份額分析：亞太地區

第 15 章 SWOT 分析

第 16 章公司簡介

  • GLAUKOS CORPORATION
  • ALCON INC.
  • ABBVIE INC.
  • JOHNSON & JOHNSON SURGICAL VISION, INC. (JOHNSON & JOHNSON子公司)
  • SANTEN PHARMACEUTICAL CO., LTD.
  • BELKIN VISION, ISRAEL
  • BVI
  • ELLEX INC.
  • IOPTIMA
  • MICROSURGICAL TECHNOLOGY. (HALMA PLC子公司)
  • NEW WORLD MEDICAL, INC.
  • NOVA EYE MEDICAL LIMITED
  • SIGHT SCIENCES.

第 17 章問卷調查

第十八章相關報導

The micro invasive glaucoma surgery (MIGS) devices market is projected to register a substantial CAGR of 33.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product (MIGS Stents, MIGS Shunts and Others), Target (Trabecular Meshwork Suprachoroidal Space Subconjunctival Filtration and Reducing Aqueous Production), Surgery Type (Glaucoma in Conjunction with Cataract and Stand-Alone Glaucoma), End User (Hospital Outpatient Departments (HOPD), Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS) and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa) - Industry Trends & Forecast to 2029

Some of the major factors contributing to the growth of the global micro invasive glaucoma surgery (MIGS) devices market are:

Increase in the geriatric population

Rising incidence of glaucoma across the world

Government initiatives to increase awareness about prevention of blindness

Market Players:

The key market players for the micro invasive glaucoma surgery (MIGS) devices market are listed below:

AbbVie

BVI

Ellex

Glaukos Corporation

Johnson and Johnson

Alcon

Microsurgical technology

New World Medical

Santen Pharmaceutical

Nova Eye Medical Limited

Belkin Vision

Sight Scientific

TABLE OF CONTENTS

1 INTRODUCTION 23

  • 1.1 OBJECTIVES OF THE STUDY 23
  • 1.2 MARKET DEFINITION 23
  • 1.3 OVERVIEW OF GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET 23
  • 1.4 LIMITATIONS 24
  • 1.5 MARKETS COVERED 24

2 MARKET SEGMENTATION 27

  • 2.1 MARKETS COVERED 27
  • 2.2 GEOGRAPHICAL SCOPE 28
  • 2.3 YEARS CONSIDERED FOR THE STUDY 29
  • 2.4 CURRENCY AND PRICING 29
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 29
  • 2.6 MULTIVARIATE MODELLING 33
  • 2.7 PRODUCTS LIFELINE CURVE 33
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
  • 2.9 DBMR MARKET POSITION GRID 35
  • 2.10 MARKET APPLICATION COVERAGE GRID 36
  • 2.11 VENDOR SHARE ANALYSIS 37
  • 2.12 SECONDARY SOURCES 38
  • 2.13 ASSUMPTIONS 38

3 EXECUTIVE SUMMARY 39

4 PREMIUM INSIGHTS 42

  • 4.1 INTERNATIONAL STANDARDS 42
  • 4.2 REGIONAL STANDARDS 42
  • 4.3 MARKET VIEWPOINT OF KEY OPINION LEADERS 42
  • 4.4 EXPECTATIONS OF FUTURE MARKET SCENARIOS 42
  • 4.5 FINDINGS AND REGIONAL TRENDS 43
  • 4.6 COMPETITIVE GROUPING 44

5 COUNTRY WISE- NO OF PROCEDURES 54

  • 5.1 NORTH AMERICA 55
  • 5.2 EUROPE 56
  • 5.3 ASIA-PACIFIC 57
  • 5.4 SOUTH AMERICA 58
  • 5.5 MIDDLE EAST AND AFRICA 59

6 REGULATION 60

  • 6.1 UNITED STATES 60
  • 6.2 EUROPE 61
  • 6.3 CHINA 62
  • 6.4 AUSTRALIA 62

7 MARKET OVERVIEW 64

  • 7.1 DRIVERS 66
    • 7.1.1 INCREASE IN THE GERIATRIC POPULATION 66
    • 7.1.2 RISE IN INCIDENCE OF GLAUCOMA ACROSS THE WORLD 66
    • 7.1.3 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT THE PREVENTION OF BLINDNESS 67
    • 7.1.4 GROWTH IN POPULARITY OF MINIMALLY INVASIVE SURGERY ACROSS THE GLOBE 67
  • 7.2 RESTRAINTS 68
    • 7.2.1 INADEQUATE REIMBURSEMENT SCENARIO 68
    • 7.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES 68
    • 7.2.3 HIGH COST OF SURGICAL PROCEDURES 68
  • 7.3 OPPORTUNITIES 69
    • 7.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES 69
    • 7.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT 69
  • 7.4 CHALLENGES 70
    • 7.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE 70
    • 7.4.2 RISKS ASSOCIATED WITH THE MICRO INVASIVE GLAUCOMA SURGERY 71

8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT 72

  • 8.1 OVERVIEW 73
  • 8.2 MIGS STENTS 76
  • 8.3 MIGS SHUNTS 76
  • 8.4 OTHERS 77

9 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET 78

  • 9.1 OVERVIEW 79
  • 9.2 TRABECULAR MESHWORK 82
  • 9.3 SUPRACHOROIDAL SPACE 82
  • 9.4 SUBCONJUNCTIVAL FILTRATION 83
  • 9.5 REDUCING AQUEOUS PRODUCTION 84

10 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE 85

  • 10.1 OVERVIEW 86
  • 10.2 GLAUCOMA IN CONJUNCTION WITH CATARACT 89
  • 10.3 STAND-ALONE GLAUCOMA 89

11 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER 91

  • 11.1 OVERVIEW 92
  • 11.2 HOSPITAL 95
  • 11.3 OPHTHALMOLOGY CLINICS 95
  • 11.4 AMBULATORY SURGERY CENTERS (ASCS) 96
  • 11.5 OTHERS 97

12 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL 98

  • 12.1 OVERVIEW 99
  • 12.2 DIRECT TENDER 102
  • 12.3 RETAIL SALES 102

13 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION 104

  • 13.1 OVERVIEW 105
  • 13.2 NORTH AMERICA 110
    • 13.2.1 U.S. 116
    • 13.2.2 CANADA 118
    • 13.2.3 MEXICO 120
  • 13.3 EUROPE 122
    • 13.3.1 GERMANY 128
    • 13.3.2 FRANCE 130
    • 13.3.3 U.K. 132
    • 13.3.4 ITALY 134
    • 13.3.5 SPAIN 136
    • 13.3.6 SWITZERLAND 138
    • 13.3.7 NETHERLANDS 140
    • 13.3.8 BELGIUM 142
    • 13.3.9 RUSSIA 144
    • 13.3.10 TURKEY 146
    • 13.3.11 REST OF EUROPE 148
  • 13.4 ASIA-PACIFIC 149
    • 13.4.1 CHINA 155
    • 13.4.2 JAPAN 157
    • 13.4.3 INDIA 159
    • 13.4.4 SOUTH KOREA 161
    • 13.4.5 AUSTRALIA 163
    • 13.4.6 SINGAPORE 165
    • 13.4.7 THAILAND 167
    • 13.4.8 MALAYSIA 169
    • 13.4.9 INDONESIA 171
    • 13.4.10 PHILIPPINES 173
    • 13.4.11 REST OF ASIA-PACIFIC 175
  • 13.5 SOUTH AMERICA 176
    • 13.5.1 BRAZIL 182
    • 13.5.2 ARGENTINA 184
    • 13.5.3 REST OF SOUTH AMERICA 186
  • 13.6 MIDDLE EAST AND AFRICA 187
    • 13.6.1 SOUTH AFRICA 193
    • 13.6.2 SAUDI ARABIA 195
    • 13.6.3 U.A.E. 197
    • 13.6.4 ISRAEL 199
    • 13.6.5 EGYPT 201
    • 13.6.6 REST OF MIDDLE EAST AND AFRICA 203

14 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE 204

  • 14.1 COMPANY SHARE ANALYSIS: GLOBAL 204
  • 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 205
  • 14.3 COMPANY SHARE ANALYSIS: EUROPE 206
  • 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 207

15 SWOT ANALYSIS 208

16 COMPANY PROFILE 209

  • 16.1 GLAUKOS CORPORATION 209
    • 16.1.1 COMPANY SNAPSHOT 209
    • 16.1.2 REVENUE ANALYSIS 209
    • 16.1.3 COMPANY SHARE ANALYSIS 210
    • 16.1.4 PRODUCT PORTFOLIO 210
      • 16.1.4.1 RECENT DEVELOPMENT 210
  • 16.2 ALCON INC. 211
    • 16.2.1 COMPANY SNAPSHOT 211
    • 16.2.2 REVENUE ANALYSIS 211
    • 16.2.3 COMPANY SHARE ANALYSIS 212
    • 16.2.4 PRODUCT PORTFOLIO 212
      • 16.2.4.1 RECENT DEVELOPMENTS 213
  • 16.3 ABBVIE INC. 214
    • 16.3.1 COMPANY SNAPSHOT 214
    • 16.3.2 REVENUE ANALYSIS 214
    • 16.3.3 COMPANY SHARE ANALYSIS 215
    • 16.3.4 PRODUCT PORTFOLIO 215
      • 16.3.4.1 RECENT DEVELOPMENT 215
  • 16.4 JOHNSON & JOHNSON SURGICAL VISION, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON) 216
    • 16.4.1 COMPANY SNAPSHOT 216
    • 16.4.2 REVENUE ANALYSIS 216
    • 16.4.3 COMPANY SHARE ANALYSIS 217
    • 16.4.4 PRODUCT PORTFOLIO 217
      • 16.4.4.1 RECENT DEVELOPMENT 217
  • 16.5 SANTEN PHARMACEUTICAL CO., LTD. 218
    • 16.5.1 COMPANY SNAPSHOT 218
    • 16.5.2 REVENUE ANALYSIS 218
    • 16.5.3 COMPANY SHARE ANALYSIS 219
    • 16.5.4 PRODUCT PORTFOLIO 219
      • 16.5.4.1 RECENT DEVELOPMENTS 219
  • 16.6 BELKIN VISION, ISRAEL 221
    • 16.6.1 COMPANY SNAPSHOT 221
    • 16.6.2 PRODUCT PORTFOLIO 221
    • 16.6.3 RECENT DEVELOPMENT 221
  • 16.7 BVI 222
    • 16.7.1 COMPANY SNAPSHOT 222
    • 16.7.2 PRODUCT PORTFOLIO 222
      • 16.7.2.1 RECENT DEVELOPMENTS 223
  • 16.8 ELLEX INC. 224
    • 16.8.1 COMPANY SNAPSHOT 224
    • 16.8.2 PRODUCT PORTFOLIO 224
      • 16.8.2.1 RECENT DEVELOPMENTS 224
  • 16.9 IOPTIMA 225
    • 16.9.1 COMPANY SNAPSHOT 225
    • 16.9.2 PRODUCT PORTFOLIO 225
    • 16.9.3 RECENT DEVELOPMENT 225
  • 16.10 MICROSURGICAL TECHNOLOGY. (A SUBSIDIARY OF HALMA PLC) 226
    • 16.10.1 COMPANY SNAPSHOT 226
    • 16.10.2 PRODUCT PORTFOLIO 226
      • 16.10.2.1 RECENT DEVELOPMENT 226
  • 16.11 NEW WORLD MEDICAL, INC. 227
    • 16.11.1 COMPANY SNAPSHOT 227
    • 16.11.2 PRODUCT PORTFOLIO 227
      • 16.11.2.1 RECENT DEVELOPMENTS 227
  • 16.12 NOVA EYE MEDICAL LIMITED 228
    • 16.12.1 COMPANY SNAPSHOT 228
    • 16.12.2 REVENUE ANALYSIS 228
    • 16.12.3 PRODUCT PORTFOLIO 229
      • 16.12.3.1 RECENT DEVELOPMENTS 229
  • 16.13 SIGHT SCIENCES. 230
    • 16.13.1 COMPANY SNAPSHOT 230
    • 16.13.2 REVENUE ANALYSIS 230
    • 16.13.3 PRODUCT PORTFOLIO 231
      • 16.13.3.1 RECENT DEVELOPMENTS 231

17 QUESTIONNAIRE 233

18 RELATED REPORTS 235

LIST OF TABLES

  • TABLE 1 NUMBER OF PEOPLE (AGED 40-80 YEARS, IN MILLIONS) WITH GLAUCOMA IN 2013 AND PROJECTION OF THE NUMBER OF PEOPLE HAVING GLAUCOMA IN 2020 AND 2040 66
  • TABLE 2 NEW OPTIONS FOR GLAUCOMA TREATMENT 69
  • TABLE 3 NUMBER OF PHYSICIANS/ THOUSAND POPULATIONS 70
  • TABLE 4 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 75
  • TABLE 5 GLOBAL MIGS STENTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 76
  • TABLE 6 GLOBAL MIGS SHUNTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 77
  • TABLE 7 GLOBAL OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 77
  • TABLE 8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 81
  • TABLE 9 GLOBAL TRABECULAR MESHWORK IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 82
  • TABLE 10 GLOBAL SUPRACHOROIDAL SPACE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 83
  • TABLE 11 GLOBAL SUBCONJUNCTIVAL FILTRATION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 84
  • TABLE 12 GLOBAL REDUCING AQUEOUS PRODUCTION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 84
  • TABLE 13 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 88
  • TABLE 14 GLOBAL GLAUCOMA IN CONJUNCTION WITH CATARACT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 89
  • TABLE 15 GLOBAL STAND-ALONE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 90
  • TABLE 16 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 94
  • TABLE 17 GLOBAL HOSPITAL IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 95
  • TABLE 18 GLOBAL OPHTHALMOLOGY CLINICS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 96
  • TABLE 19 GLOBAL AMBULATORY SURGERY CENTERS (ASCS) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 96
  • TABLE 20 GLOBAL OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 97
  • TABLE 21 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 101
  • TABLE 22 GLOBAL DIRECT TENDER IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 102
  • TABLE 23 GLOBAL RETAIL SALES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 103
  • TABLE 24 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION) 109
  • TABLE 25 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 114
  • TABLE 26 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 114
  • TABLE 27 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 114
  • TABLE 28 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 114
  • TABLE 29 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 115
  • TABLE 30 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 115
  • TABLE 31 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 116
  • TABLE 32 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 116
  • TABLE 33 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 116
  • TABLE 34 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 116
  • TABLE 35 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 117
  • TABLE 36 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 118
  • TABLE 37 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 118
  • TABLE 38 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 118
  • TABLE 39 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 118
  • TABLE 40 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 119
  • TABLE 41 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 120
  • TABLE 42 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 120
  • TABLE 43 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 120
  • TABLE 44 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 120
  • TABLE 45 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 121
  • TABLE 46 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 126
  • TABLE 47 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 126
  • TABLE 48 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 126
  • TABLE 49 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 127
  • TABLE 50 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 127
  • TABLE 51 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 127
  • TABLE 52 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 128
  • TABLE 53 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 128
  • TABLE 54 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 128
  • TABLE 55 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 128
  • TABLE 56 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 129
  • TABLE 57 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 130
  • TABLE 58 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 130
  • TABLE 59 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 130
  • TABLE 60 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 130
  • TABLE 61 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 131
  • TABLE 62 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 132
  • TABLE 63 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 132
  • TABLE 64 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 65 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 132
  • TABLE 66 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 133
  • TABLE 67 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 134
  • TABLE 68 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 134
  • TABLE 69 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 70 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 134
  • TABLE 71 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 135
  • TABLE 72 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 136
  • TABLE 73 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 136
  • TABLE 74 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 136
  • TABLE 75 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 136
  • TABLE 76 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 137
  • TABLE 77 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 138
  • TABLE 78 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 138
  • TABLE 79 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 138
  • TABLE 80 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 138
  • TABLE 81 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 139
  • TABLE 82 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 140
  • TABLE 83 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 140
  • TABLE 84 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 85 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 140
  • TABLE 86 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 141
  • TABLE 87 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 142
  • TABLE 88 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 142
  • TABLE 89 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 142
  • TABLE 90 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 142
  • TABLE 91 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 143
  • TABLE 92 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 144
  • TABLE 93 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 144
  • TABLE 94 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 95 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 144
  • TABLE 96 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 145
  • TABLE 97 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 146
  • TABLE 98 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 146
  • TABLE 99 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 100 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 146
  • TABLE 101 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 147
  • TABLE 102 REST OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 148
  • TABLE 103 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 153
  • TABLE 104 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 153
  • TABLE 105 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 153
  • TABLE 106 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 107 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 154
  • TABLE 108 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 154
  • TABLE 109 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 155
  • TABLE 110 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 155
  • TABLE 111 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 155
  • TABLE 112 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 155
  • TABLE 113 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 156
  • TABLE 114 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 157
  • TABLE 115 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 157
  • TABLE 116 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 157
  • TABLE 117 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 157
  • TABLE 118 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 158
  • TABLE 119 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 159
  • TABLE 120 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 159
  • TABLE 121 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 159
  • TABLE 122 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 159
  • TABLE 123 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 160
  • TABLE 124 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 161
  • TABLE 125 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 161
  • TABLE 126 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 161
  • TABLE 127 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 161
  • TABLE 128 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 162
  • TABLE 129 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 163
  • TABLE 130 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 163
  • TABLE 131 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 163
  • TABLE 132 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 163
  • TABLE 133 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 164
  • TABLE 134 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 165
  • TABLE 135 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 165
  • TABLE 136 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 165
  • TABLE 137 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 165
  • TABLE 138 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 166
  • TABLE 139 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 167
  • TABLE 140 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 167
  • TABLE 141 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 167
  • TABLE 142 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 167
  • TABLE 143 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 168
  • TABLE 144 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 169
  • TABLE 145 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 169
  • TABLE 146 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 169
  • TABLE 147 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 169
  • TABLE 148 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 170
  • TABLE 149 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 171
  • TABLE 150 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 171
  • TABLE 151 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 171
  • TABLE 152 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 171
  • TABLE 153 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 172
  • TABLE 154 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 173
  • TABLE 155 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 173
  • TABLE 156 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 173
  • TABLE 157 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 173
  • TABLE 158 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 174
  • TABLE 159 REST OF ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 175
  • TABLE 160 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 180
  • TABLE 161 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 180
  • TABLE 162 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 180
  • TABLE 163 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 180
  • TABLE 164 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 181
  • TABLE 165 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 181
  • TABLE 166 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 182
  • TABLE 167 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 182
  • TABLE 168 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 182
  • TABLE 169 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 182
  • TABLE 170 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 183
  • TABLE 171 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 184
  • TABLE 172 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 184
  • TABLE 173 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 184
  • TABLE 174 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 184
  • TABLE 175 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 185
  • TABLE 176 REST OF SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 186
  • TABLE 177 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 191
  • TABLE 178 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 191
  • TABLE 179 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 191
  • TABLE 180 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 191
  • TABLE 181 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 192
  • TABLE 182 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 192
  • TABLE 183 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 193
  • TABLE 184 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 193
  • TABLE 185 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 193
  • TABLE 186 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 193
  • TABLE 187 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 194
  • TABLE 188 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 195
  • TABLE 189 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 195
  • TABLE 190 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 195
  • TABLE 191 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 195
  • TABLE 192 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 196
  • TABLE 193 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 197
  • TABLE 194 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 197
  • TABLE 195 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 197
  • TABLE 196 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 197
  • TABLE 197 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 198
  • TABLE 198 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 199
  • TABLE 199 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 199
  • TABLE 200 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 199
  • TABLE 201 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 199
  • TABLE 202 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 200
  • TABLE 203 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 201
  • TABLE 204 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION) 201
  • TABLE 205 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 201
  • TABLE 206 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION) 201
  • TABLE 207 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 202
  • TABLE 208 REST OF MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 203